EDMOND DE ROTHSCHILD HOLDING S.A. - INSYS THERAPEUTICS INC NEW ownership

INSYS THERAPEUTICS INC NEW's ticker is INSYQ and the CUSIP is 45824V209. A total of 110 filers reported holding INSYS THERAPEUTICS INC NEW in Q1 2018. The put-call ratio across all filers is 1.90 and the average weighting 0.0%.

Quarter-by-quarter ownership
EDMOND DE ROTHSCHILD HOLDING S.A. ownership history of INSYS THERAPEUTICS INC NEW
ValueSharesWeighting
Q1 2019$10,000
+25.0%
2,2000.0%0.00%
Q4 2018$8,000
-63.6%
2,2000.0%0.00%
-100.0%
Q3 2018$22,000
+37.5%
2,2000.0%0.00%
Q2 2018$16,000
+23.1%
2,2000.0%0.00%
Q1 2018$13,000
-38.1%
2,2000.0%0.00%
-100.0%
Q4 2017$21,000
+5.0%
2,2000.0%0.00%0.0%
Q3 2017$20,000
-28.6%
2,2000.0%0.00%0.0%
Q2 2017$28,000
+21.7%
2,2000.0%0.00%0.0%
Q1 2017$23,000
+15.0%
2,2000.0%0.00%0.0%
Q4 2016$20,000
-4.8%
2,200
+193.3%
0.00%0.0%
Q4 2015$21,0007500.00%
Other shareholders
INSYS THERAPEUTICS INC NEW shareholders Q1 2018
NameSharesValueWeighting ↓
Consonance Capital Management LP 697,763$27,010,0004.43%
Tamarack Capital Management, LLC 235,000$9,097,0002.15%
BOGLE INVESTMENT MANAGEMENT L P /DE/ 196,117$7,591,0000.64%
EMERALD MUTUAL FUND ADVISERS TRUST 132,862$6,093,0000.36%
EMERALD ADVISERS, LLC 118,242$4,577,0000.25%
PDT Partners, LLC 30,038$1,163,0000.14%
DRIEHAUS CAPITAL MANAGEMENT LLC 96,334$3,729,0000.14%
Convergence Investment Partners, LLC 17,450$675,0000.11%
ROTHSCHILD & CO ASSET MANAGEMENT US INC. 122,556$4,744,0000.11%
Spark Investment Management LLC 13,992$541,0000.09%
View complete list of INSYS THERAPEUTICS INC NEW shareholders